Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

05.09.2022

2 AIDS
1 BMC Pediatr
14 Clin Infect Dis
1 J Infect
3 J Infect Dis
1 JAMA
1 Lancet
6 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
1 Nat Med
1 PLoS Med
10 PLoS One
1 Proc Natl Acad Sci U S A
19 Vaccine
1 Virology
2 Virus Res



    AIDS

  1. WONG NS, Wong BCK, Chan JMC, Wong KH, et al
    Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors' reply.
    AIDS. 2022;36:1747-1748.
    >> Share

  2. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV.
    AIDS. 2022;36:1746-1747.
    >> Share


    BMC Pediatr

  3. KATZ J, Labilloy A, Lee A
    Recurrent, non-traumatic, non-exertional rhabdomyolysis after immunologic stimuli in a healthy adolescent female: a case report.
    BMC Pediatr. 2022;22:515.
    >> Share


    Clin Infect Dis

  4. SNYMAN J, Hwa SH, Krause R, Muema D, et al
    Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave.
    Clin Infect Dis. 2021 Sep 2. pii: 6362722. doi: 10.1093.
    >> Share

  5. LUNDBO LF, Harboe ZB, Sandholdt H, Smith-Hansen L, et al
    Comorbidity increases the risk of invasive meningococcal disease in adults.
    Clin Infect Dis. 2021 Sep 27. pii: 6375918. doi: 10.1093.
    >> Share

  6. ANDREJKO K, Ratnasiri B, Lewnard JA
    Association of Pneumococcal Serotype With Susceptibility to Antimicrobial Drugs: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2022;75:131-140.
    >> Share

  7. BANERJEE E, Paul P, Griffith J, Laine E, et al
    Impact of Isolation and Exclusion as a Public Health Strategy to Contain Measles Virus Transmission During a Measles Outbreak.
    Clin Infect Dis. 2022;75:152-154.
    >> Share

  8. ORIJE MRP, Garcia-Fogeda I, Van Dyck W, Corbiere V, et al
    Impact of Maternal Pertussis Antibodies on the Infants' Cellular Immune Responses.
    Clin Infect Dis. 2022;75:442-452.
    >> Share

  9. MATHIS AD, Clemmons NS, Redd SB, Pham H, et al
    Maintenance of Measles Elimination Status in the United States for 20 Years Despite Increasing Challenges.
    Clin Infect Dis. 2022;75:416-424.
    >> Share

  10. MILLER AD, Zambrano LD, Yousaf AR, Abrams JY, et al
    Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021.
    Clin Infect Dis. 2021 Dec 5. pii: 6453395. doi: 10.1093/cid/ciab1007.
    >> Share

  11. DANINO D, Ben-Shimol S, Van Der Beek BA, Givon-Lavi N, et al
    Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study.
    Clin Infect Dis. 2021 Dec 14. pii: 6460745. doi: 10.1093/cid/ciab1014.
    >> Share

  12. CROMER D, Reynaldi A, Steain M, Triccas JA, et al
    Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial.
    Clin Infect Dis. 2022 Feb 1. pii: 6518223. doi: 10.1093.
    >> Share

  13. AMIN AB, Tate JE, Waller LA, Lash TL, et al
    Monovalent rotavirus vaccine efficacy against different rotavirus genotypes: a pooled analysis of Phase II and III trial data.
    Clin Infect Dis. 2022 Aug 29. pii: 6678127. doi: 10.1093.
    >> Share

  14. GAGLANI M, Kim SS, Naleway AL, Levine MZ, et al
    Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
    Clin Infect Dis. 2022 Aug 29. pii: 6678123. doi: 10.1093.
    >> Share

  15. WIRTH KE, Edwards JK, Feinstein L, Breskin A, et al
    When emulating a trial, do as the trialists do: Missteps in estimating relative effectiveness of a SARS-CoV-2 vaccine booster dose.
    Clin Infect Dis. 2022 Aug 30. pii: 6679241. doi: 10.1093.
    >> Share

  16. DE SILVA A
    Safety of Dengue Vaccine?
    Clin Infect Dis. 2022 Sep 1. pii: 6681127. doi: 10.1093.
    >> Share

  17. VAN DIJCK C, Hens N, Kenyon C, Tsoumanis A, et al
    The roles of unrecognized monkeypox cases, contact isolation and vaccination in determining epidemic size in Belgium. A modelling study.
    Clin Infect Dis. 2022 Sep 2. pii: 6686539. doi: 10.1093.
    >> Share


    J Infect

  18. GIDARI A, Schiaroli E, Sabbatini S, Bastianelli S, et al
    Impact of SARS-CoV-2 Omicron Variants on Serum Neutralization in a Cohort of Healthcare Workers Vaccinated with BNT162b2.
    J Infect. 2022 Aug 25. pii: S0163-4453(22)00507.
    >> Share


    J Infect Dis

  19. YANG B, Wong IOL, Xiao J, Tsang TK, et al
    Effectiveness of CoronaVac and BNT162b2 vaccine against SARS-CoV-2 Omicron BA.2 infections in Hong Kong.
    J Infect Dis. 2022 Sep 2. pii: 6687716. doi: 10.1093.
    >> Share

  20. SHAW AG, Cooper LV, Gumede N, Bandyopadhyay AS, et al
    Time Taken to Detect and Respond to Polio Outbreaks in Africa and the Potential Impact of Direct Molecular Detection and Nanopore Sequencing.
    J Infect Dis. 2022;226:453-462.
    >> Share

  21. SADOFF J, De Paepe E, DeVincenzo J, Gymnopoulou E, et al
    Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study.
    J Infect Dis. 2022;226:396-406.
    >> Share


    JAMA

  22. CULLEN JP, Russ S, Russell HA
    Theater for Vaccine Hesitancy-Setting the Stage for Difficult Conversations.
    JAMA. 2022 Sep 2. pii: 2796160. doi: 10.1001/jama.2022.14864.
    >> Share


    Lancet

  23. UYEKI TM, Hui DS, Zambon M, Wentworth DE, et al
    Influenza.
    Lancet. 2022;400:693-706.
    >> Share


    MMWR Morb Mortal Wkly Rep

  24. FAST HE, Murthy BP, Zell E, Meng L, et al
    Booster COVID-19 Vaccinations Among Persons Aged >/=5 Years and Second Booster COVID-19 Vaccinations Among Persons Aged >/=50 Years - United States, August 13, 2021-August 5, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1121-1125.
    >> Share

  25. HAUSE AM, Marquez P, Zhang B, Myers TR, et al
    COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months-5 Years - United States, June 18, 2022-August 21, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1115-1120.
    >> Share

  26. PINGALI C, Yankey D, Elam-Evans LD, Markowitz LE, et al
    National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:1101-1108.
    >> Share

  27. LUTRICK K, Fowlkes A, Rivers P, Herder K, et al
    Parental Intentions and Perceptions Toward COVID-19 Vaccination Among Children Aged 4 Months to 4 Years - PROTECT Cohort, Four States, July 2021-May 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1109-1114.
    >> Share

  28. HAVERS FP, Patel K, Whitaker M, Milucky J, et al
    Laboratory-Confirmed COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance - COVID-19-Associated Hospitalization Surveillance Network, 14 States, June 20, 2021-May 31, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1085-1091.
    >> Share

  29. LATZER M, Pieracci EG, Altenburger A, Stauffer KE, et al
    Review of CDC's Suspension of and Advance Written Approval Process for Dogs Entering the United States from Egypt - May 2019-December 2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:1081-1084.
    >> Share


    N Engl J Med

  30. BROOKS JT, Marks P, Goldstein RH, Walensky RP, et al
    Intradermal Vaccination for Monkeypox - Benefits for Individual and Public Health.
    N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMp2211311.
    >> Share

  31. BAROUCH DH
    Covid-19 Vaccines - Immunity, Variants, Boosters.
    N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMra2206573.
    >> Share


    Nat Med

  32. CARVALHO T
    mRNA vaccines boost BioNTech's CAR T cell therapy.
    Nat Med. 2022 Sep 1. pii: 10.1038/d41591-022-00091.
    >> Share


    PLoS Med

  33. GRAM MA, Emborg HD, Schelde AB, Friis NU, et al
    Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    PLoS Med. 2022;19:e1003992.
    >> Share


    PLoS One

  34. KYEI-ARTHUR F, Kyei-Gyamfi S, Agyekum MW, Afrifa-Anane GF, et al
    Parents' and guardians' acceptability of COVID-19 vaccination for children in Ghana: An online survey.
    PLoS One. 2022;17:e0272801.
    >> Share

  35. SANNEH B, Sanneh S, Lareef-Jah S, Darboe B, et al
    Practice of preventive measures and vaccine hesitance for COVID 19 among households in The Gambia, 2021: Study protocol.
    PLoS One. 2022;17:e0270304.
    >> Share

  36. NASIRI O, Hajihassani M, Noori Goodarzi N, Fereshteh S, et al
    Reverse vaccinology approach to identify novel and immunogenic targets against Porphyromonas gingivalis: An in silico study.
    PLoS One. 2022;17:e0273770.
    >> Share

  37. BEHMARD E, Abdulabbas HT, Abdalkareem Jasim S, Najafipour S, et al
    Design of a novel multi-epitope vaccine candidate against hepatitis C virus using structural and nonstructural proteins: An immunoinformatics approach.
    PLoS One. 2022;17:e0272582.
    >> Share

  38. WAGGLE KD, Griffith MP, Zhu L, Cooper VS, et al
    Genomic characterization of SARS-CoV-2 from vaccine breakthrough cases in Allegheny County, Pennsylvania.
    PLoS One. 2022;17:e0272954.
    >> Share

  39. LEE KW, Gew LT, Siau CS, Peh SC, et al
    COVID-19 vaccine hesitancy and its associated factors in Malaysia.
    PLoS One. 2022;17:e0266925.
    >> Share

  40. WASSERBAUER M, Hlava S, Trojanek M, Stovicek J, et al
    Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study.
    PLoS One. 2022;17:e0273612.
    >> Share

  41. JIANG F, Zhao Y, Bai J, Yang X, et al
    Perceived health literacy and COVID-19 vaccine acceptance among Chinese college students: A mediation analysis.
    PLoS One. 2022;17:e0273285.
    >> Share

  42. BURATTO A, Muttoni M, Wrzaczek S, Freiberger M, et al
    Should the COVID-19 lockdown be relaxed or intensified in case a vaccine becomes available?
    PLoS One. 2022;17:e0273557.
    >> Share

  43. STERNJAKOB-MARTHALER A, Berko-Gottel B, Rissland J, Schope J, et al
    Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates.
    PLoS One. 2022;17:e0273332.
    >> Share


    Proc Natl Acad Sci U S A

  44. VAN BEEK M, Nussenzweig MC, Chakraborty AK
    Two complementary features of humoral immune memory confer protection against the same or variant antigens.
    Proc Natl Acad Sci U S A. 2022;119:e2205598119.
    >> Share


    Vaccine

  45. ROSHCHINA Y, Roshchin S, Rozhkova K
    Determinants of COVID-19 vaccine hesitancy and resistance in Russia.
    Vaccine. 2022 Aug 26. pii: S0264-410X(22)01032.
    >> Share

  46. KAMAL HOSSAIN M, Hassanzadeganroudsari M, Feehan J, Deraos G, et al
    Development and characterization of a novel conjugated methamphetamine vaccine.
    Vaccine. 2022 Aug 27. pii: S0264-410X(22)01033.
    >> Share

  47. DOYON-PLOURDE P, Fortin E, Quach C
    Evaluation of the 2018-2019 vaccine effectiveness against medically attended influenza-like illness using medical records and claims data.
    Vaccine. 2022 Aug 27. pii: S0264-410X(22)00976.
    >> Share

  48. TERESA VIETRI M, D'Elia G, Caliendo G, Passariello L, et al
    Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection.
    Vaccine. 2022 Aug 26. pii: S0264-410X(22)01034.
    >> Share

  49. MARRON L, Ferenczi A, O'Brien KM, Cotter S, et al
    Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01013.
    >> Share

  50. STIVANELLO E, Beghelli C, Cardoni F, Giansante C, et al
    Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01029.
    >> Share

  51. WANG X, Deng Y, Zhao L, Wang L, et al
    Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01030.
    >> Share

  52. KANOKUDOM S, Assawakosri S, Suntronwong N, Chansaenroj J, et al
    Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01011.
    >> Share

  53. DOCHEZ C, Duclos P, MacDonald N, Steffen C, et al
    Advanced vaccinology training globally: Update and impact of the COVID-19 crisis.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01006.
    >> Share

  54. CATHARINA DE BEER J, Goto D, Miller-Janson H, Holl R, et al
    Vaccine financing in the Middle East and Africa: An overview from 2010 to 2019.
    Vaccine. 2022 Aug 24. pii: S0264-410X(22)00817.
    >> Share

  55. CALO WA, Lennon RP, Ruffin Iv MT, Keller C, et al
    Support for HPV vaccine school-entry requirements in the United States: The role of exemption policies.
    Vaccine. 2022 Aug 24. pii: S0264-410X(22)00983.
    >> Share

  56. KURASHIMA K, Numano T, Yoshino A, Osawa A, et al
    Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01027.
    >> Share

  57. CHUAN VOO T, Savulescu J, Schaefer O, Ho Zhi Ling A, et al
    COVID-19 differentiated measures for unvaccinated individuals: The need for clear goals and strong justifications.
    Vaccine. 2022;40:5333-5337.
    >> Share

  58. PHAM D, Shukla A, Welch K, Villa A, et al
    Assessing knowledge of human papillomavirus among men who have sex with men (MSM) using targeted dating applications.
    Vaccine. 2022;40:5376-5383.
    >> Share

  59. ESSON R, Rodrigues De Sousa E, Benair L, Devard N, et al
    Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate.
    Vaccine. 2022 Aug 23. pii: S0264-410X(22)00939.
    >> Share

  60. TOAPANTA-YANCHAPAXI L, Chiquete E, Avila-Rojo E, Lopez-Yanez S, et al
    Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01012.
    >> Share

  61. MATSUURA T, Fukushima W, Nakagama Y, Kido Y, et al
    Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan.
    Vaccine. 2022 Aug 15. pii: S0264-410X(22)00984.
    >> Share

  62. WILLIS GA, Bloomfield L, Berry M, Bulsara C, et al
    The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students.
    Vaccine. 2022 Aug 22. pii: S0264-410X(22)01026.
    >> Share

  63. LIM AH, Ab Rahman N, Ong SM, Paraja J, et al
    Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study.
    Vaccine. 2022 Aug 24. pii: S0264-410X(22)01005.
    >> Share


    Virology

  64. OH J, Subbiah J, Kim KH, Park BR, et al
    Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses.
    Virology. 2022;574:37-46.
    >> Share


    Virus Res

  65. ZHENZHONG W, Chuanxiang Q, Shengqiang G, Jinming L, et al
    Genetic variation and evolution of attenuated African swine fever virus strain isolated in the field: A review.
    Virus Res. 2022;319:198874.
    >> Share

  66. HOU LN, Wang FX, Wang YX, Guo H, et al
    Subunit vaccine based on glycoprotein B protects pattern animal guinea pigs from tissue damage caused by infectious bovine rhinotracheitis virus.
    Virus Res. 2022;320:198899.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016